Skip to main content
Clinical Trials/CTRI/2020/11/028833
CTRI/2020/11/028833
Not yet recruiting
Phase 2

Single arm clinical study to evaluate the effect of nagbala kshirpak in management of essential hypertension

Samkit Shah0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Samkit Shah
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Samkit Shah

Eligibility Criteria

Inclusion Criteria

  • 1\)Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg.
  • 2\)Diastolic Blood Pressure: less than or equal to 110 mm of Hg or More than 90 mm of Hg.
  • 3\)Patient willing to enroll in the research \& to sign the consent form

Exclusion Criteria

  • 1\)Patient who have past history of atrial fibrillation, acute coronary syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia in last 6 months.
  • 2\)Symptomatic patients with clinical features of early heart failure.
  • 3\)Secondary hypertension.
  • 4\)Women who are pregnant and lactating or on estrogen replacement therapy.
  • 5\)Alcoholics and drug abusers.
  • 6\)Accelerated and malignant hypertension.

Outcomes

Primary Outcomes

Not specified

Similar Trials